BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11060818)

  • 1. Therapeutic potential of H(3)-receptor agonists in myocardial infarction.
    Mackins CJ; Levi R
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2537-42. PubMed ID: 11060818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H(3)-receptors: a new frontier in myocardial ischemia.
    Levi R; Smith NC
    J Pharmacol Exp Ther; 2000 Mar; 292(3):825-30. PubMed ID: 10688593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors.
    Imamura M; Lander HM; Levi R
    Circ Res; 1996 Mar; 78(3):475-81. PubMed ID: 8593706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.
    Hashikawa-Hobara N; Chan NY; Levi R
    J Pharmacol Exp Ther; 2012 Jan; 340(1):185-91. PubMed ID: 22011436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of angiotensin II AT1 receptors to neuronal NHE activity and carrier-mediated norepinephrine release in myocardial ischemia.
    Reid AC; Mackins CJ; Seyedi N; Levi R; Silver RB
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1448-54. PubMed ID: 14684374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and role of the presynaptic and myocardial Na+/H+ exchanger NHE1: effects on the sympathetic nervous system in heart failure.
    Leineweber K; Heusch G; Schulz R
    Cardiovasc Drug Rev; 2007; 25(2):123-31. PubMed ID: 17614935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings.
    Silver RB; Poonwasi KS; Seyedi N; Wilson SJ; Lovenberg TW; Levi R
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):501-6. PubMed ID: 11752397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catecholamine release and arrhythmias in acute myocardial ischaemia.
    Schömig A; Haass M; Richardt G
    Eur Heart J; 1991 Dec; 12 Suppl F():38-47. PubMed ID: 1804638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia.
    Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R
    J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H3-receptor signaling in cardiac sympathetic nerves: Identification of a novel MAPK-PLA2-COX-PGE2-EP3R pathway.
    Levi R; Seyedi N; Schaefer U; Estephan R; Mackins CJ; Tyler E; Silver RB
    Biochem Pharmacol; 2007 Apr; 73(8):1146-56. PubMed ID: 17266940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SM-20550, a new Na+/H+ exchange inhibitor and its cardioprotective effect in ischemic/reperfused isolated rat hearts by preventing Ca2+-overload.
    Yamamoto S; Matsui K; Kitano M; Ohashi N
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):855-62. PubMed ID: 10836718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
    Endou M; Poli E; Levi R
    J Pharmacol Exp Ther; 1994 Apr; 269(1):221-9. PubMed ID: 8169830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-mediated norepinephrine release and reperfusion arrhythmias induced by protracted ischemia in isolated perfused guinea pig hearts: effect of presynaptic modulation by alpha(2)-adrenoceptor in mild hypothermic ischemia.
    Oka J; Imamura M; Hatta E; Maruyama R; Isaka M; Murashita T; Yasuda K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):681-7. PubMed ID: 12388651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines in myocardial ischemia. Systemic and cardiac release.
    Schömig A
    Circulation; 1990 Sep; 82(3 Suppl):II13-22. PubMed ID: 2203558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia.
    Silver RB; Mackins CJ; Smith NC; Koritchneva IL; Lefkowitz K; Lovenberg TW; Levi R
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2855-9. PubMed ID: 11226330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FR183998, a Na+/H+ exchange inhibitor, suppresses both IL-8 content and myocardial infarct size in a cardiac ischaemia-reperfusion model in rats.
    Ohara F; Ohkubo K; Maeda K; Seki J; Goto T
    J Pharm Pharmacol; 2002 Feb; 54(2):263-8. PubMed ID: 11848290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptide-induced catecholamine release from cardiac sympathetic neurons: inhibition by histamine H3 and H4 receptor activation.
    Chan NY; Robador PA; Levi R
    J Pharmacol Exp Ther; 2012 Dec; 343(3):568-77. PubMed ID: 22923736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of the Na+/H+ exchanger contributes to cardiac damage following ischaemia and reperfusion.
    Allen DG; Xiao XH
    Clin Exp Pharmacol Physiol; 2000 Sep; 27(9):727-33. PubMed ID: 10972541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is timing everything? Therapeutic potential of modulators of cardiac Na(+) transporters.
    Doggrell SA; Hancox JC
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1123-42. PubMed ID: 12831348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.